NM_014140.4:c.127G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014140.4(SMARCAL1):​c.127G>A​(p.Ala43Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00247 in 1,614,194 control chromosomes in the GnomAD database, including 79 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A43V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.013 ( 47 hom., cov: 33)
Exomes 𝑓: 0.0013 ( 32 hom. )

Consequence

SMARCAL1
NM_014140.4 missense

Scores

1
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.407

Publications

5 publications found
Variant links:
Genes affected
SMARCAL1 (HGNC:11102): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1) The protein encoded by this gene is a member of the SWI/SNF family of proteins. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein shows sequence similarity to the E. coli RNA polymerase-binding protein HepA. Mutations in this gene are a cause of Schimke immunoosseous dysplasia (SIOD), an autosomal recessive disorder with the diagnostic features of spondyloepiphyseal dysplasia, renal dysfunction, and T-cell immunodeficiency. [provided by RefSeq, Jul 2008]
SMARCAL1 Gene-Disease associations (from GenCC):
  • Schimke immuno-osseous dysplasia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, PanelApp Australia, Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0022759438).
BP6
Variant 2-216414831-G-A is Benign according to our data. Variant chr2-216414831-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260337.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0133 (2029/152300) while in subpopulation AFR AF = 0.0465 (1934/41554). AF 95% confidence interval is 0.0448. There are 47 homozygotes in GnomAd4. There are 969 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 47 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014140.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCAL1
NM_014140.4
MANE Select
c.127G>Ap.Ala43Thr
missense
Exon 3 of 18NP_054859.2
SMARCAL1
NM_001127207.2
c.127G>Ap.Ala43Thr
missense
Exon 3 of 18NP_001120679.1Q9NZC9

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCAL1
ENST00000357276.9
TSL:2 MANE Select
c.127G>Ap.Ala43Thr
missense
Exon 3 of 18ENSP00000349823.4Q9NZC9
SMARCAL1
ENST00000358207.9
TSL:1
c.127G>Ap.Ala43Thr
missense
Exon 3 of 18ENSP00000350940.5Q9NZC9
SMARCAL1
ENST00000932386.1
c.127G>Ap.Ala43Thr
missense
Exon 3 of 19ENSP00000602445.1

Frequencies

GnomAD3 genomes
AF:
0.0133
AC:
2030
AN:
152182
Hom.:
47
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0467
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00373
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00907
GnomAD2 exomes
AF:
0.00335
AC:
842
AN:
251470
AF XY:
0.00235
show subpopulations
Gnomad AFR exome
AF:
0.0448
Gnomad AMR exome
AF:
0.00234
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000141
Gnomad OTH exome
AF:
0.00212
GnomAD4 exome
AF:
0.00134
AC:
1957
AN:
1461894
Hom.:
32
Cov.:
32
AF XY:
0.00112
AC XY:
813
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.0458
AC:
1533
AN:
33480
American (AMR)
AF:
0.00250
AC:
112
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000696
AC:
6
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00295
AC:
17
AN:
5768
European-Non Finnish (NFE)
AF:
0.000112
AC:
124
AN:
1112012
Other (OTH)
AF:
0.00273
AC:
165
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
130
261
391
522
652
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0133
AC:
2029
AN:
152300
Hom.:
47
Cov.:
33
AF XY:
0.0130
AC XY:
969
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.0465
AC:
1934
AN:
41554
American (AMR)
AF:
0.00373
AC:
57
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68030
Other (OTH)
AF:
0.00898
AC:
19
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
98
195
293
390
488
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00530
Hom.:
39
Bravo
AF:
0.0152
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0474
AC:
209
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.00402
AC:
488
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
Schimke immuno-osseous dysplasia (4)
-
-
3
not provided (3)
-
-
2
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
3.8
DANN
Benign
0.93
DEOGEN2
Benign
0.013
T
Eigen
Benign
-0.93
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.55
T
MetaRNN
Benign
0.0023
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.9
L
PhyloP100
0.41
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.70
N
REVEL
Benign
0.010
Sift
Benign
0.19
T
Sift4G
Pathogenic
0.0
D
Polyphen
0.0020
B
Vest4
0.052
MVP
0.24
MPC
0.22
ClinPred
0.0026
T
GERP RS
0.32
PromoterAI
0.0015
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.028
gMVP
0.14
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2066524; hg19: chr2-217279554; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.